🇺🇸 FDA
Patent

US 11117955

Anti-Zika virus antibodies and methods of use

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11117955 (Anti-Zika virus antibodies and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P17/02